PURA VIDA INVESTMENTS, LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.

Quarter-by-quarter ownership
PURA VIDA INVESTMENTS, LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$7,563,000
+18.6%
104,073
+93.0%
0.24%
+6.1%
Q4 2021$6,377,000
+13.0%
53,929
+28.2%
0.23%
+34.3%
Q3 2021$5,642,000
-83.8%
42,059
-80.4%
0.17%
-84.1%
Q2 2021$34,794,000
+11.7%
214,900
-44.7%
1.08%
+21.8%
Q1 2021$31,163,000388,3000.89%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders